This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
healthcare: Archive
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?
by Kaibalya Pravo Dey
UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.
UNHPositive Net Change HUMNegative Net Change ELVPositive Net Change
healthcare hmo insurance medical
Leading Women-Run Companies Shaping the Future of Business
by Shrabana Mukherjee
CNC, DAR, GD, FCEL and CC stocks show how women-led companies are redefining growth with discipline, agility and results.
GDNegative Net Change DARNegative Net Change CNCPositive Net Change FCELPositive Net Change CCPositive Net Change
energy finance healthcare thematic
CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks
by Zacks Equity Research
CVS Health lifts its 2026 outlook on Aetna's recovery and retail strength while flagging 2027 pressure from 340B changes and Caremark membership declines.
CVSNegative Net Change
earnings healthcare
UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?
by Rajshree Sipani
UNH's diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.
UNHPositive Net Change CNCPositive Net Change
artificial-intelligence automation cancer healthcare hmo hospitals insurance insurance-premium medical pharmaceuticals smart-health staffing
UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?
by Kaibalya Pravo Dey
UNH's improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.
UNHPositive Net Change MOHPositive Net Change CNCPositive Net Change
earnings-report earnings-surprise healthcare hmo insurance medical
2 Microcaps With Gross Margin Catalysts
by Mark Zinski
CSBR and CEPL have levers in place for Gross Margin improvement.
CSBRNegative Net Change CEPLPositive Net Change
cancer energy healthcare utilities
Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates
by Kaibalya Pravo Dey
CNC reports Q2 results July 28 as investors weigh improving profitability against membership declines and revenue pressure ahead of earnings.
CNCPositive Net Change HUMNegative Net Change MOHPositive Net Change
earnings-outlook earnings-preview healthcare hmo insurance medical
UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
by Zacks Equity Research
UNH lifts its 2026 outlook as Medicare and Optum improve, while commercial cost pressures delay margin recovery and keep management focused on execution.
UNHPositive Net Change
earnings healthcare
Centene Stock Soars 66% YTD: Should Investors Chase the Rally?
by Kaibalya Pravo Dey
CNC stock's 66% rally reflects improving margins, stronger cash flow and renewed earnings growth, but can the turnaround keep gaining momentum?
CNCPositive Net Change UNHPositive Net Change ELVPositive Net Change
healthcare hmo insurance medical
Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch
by Kaibalya Pravo Dey
UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.
UNHPositive Net Change HUMNegative Net Change MOHPositive Net Change
earnings-outlook earnings-preview healthcare hmo insurance